Reducing The Burden Of Alcohol And Other Drug Use In Australia
Funder
National Health and Medical Research Council
Funding Amount
$250,805.00
Summary
Innovative research undertaken during the Fellowship program will provide new evidence of how best to respond to alcohol and other drug use. Partnerships with policymakers will ensure this evidence underpins Australian alcohol and other drug policy.
Reducing The Key Alcohol And Other Drug Related Harms In Australia
Funder
National Health and Medical Research Council
Funding Amount
$782,370.00
Summary
I am a leading alcohol and other drug researcher with an established national and international reputation for high quality research and translation. Over the next five years I will tackle the three key issues in the alcohol and other drug field: injecting drug use, methamphetamine use and harms and high risk drinking by young people, by developing, implementing and testing new interventions.
Reducing The Impact Of Blood Borne Viruses And Sexually Transmitted Infections In Young People.
Funder
National Health and Medical Research Council
Funding Amount
$851,980.00
Summary
Over the next five years I will undertake a program of research centred on reducing the impact of blood-borne viruses and sexually transmitted infections in vulnerable populations, particularly focusing on HCV and HIV elimination. I will use innovative systems and methods to study how these infections are transmitted and develop interventions that reduce disease transmission and associated risk-behaviours (drug and alcohol use and sexual behaviours) and increased testing and treatment.
Preventing Infectious Disease In Vulnerable Populations: Smarter Surveillance, Enhanced Epidemiology And Targeted Trials
Funder
National Health and Medical Research Council
Funding Amount
$631,010.00
Summary
Vulnerable populations, including people who inject drugs and female sex workers, are susceptible to infectious diseases such as HIV and hepatitis C. Preventing the transmission of these infections presents major challenges. The proposed research will 1) develop innovative approaches to identifying and understanding infectious disease in vulnerable populations; 2) improve our responses by designing and testing new approaches to prevention; and 3) reduce associated morbidity and mortality.
Innovative Approaches To Reducing The Impact Of Blood Borne Viruses And Sexually Transmitted Infections On Young People.
Funder
National Health and Medical Research Council
Funding Amount
$246,859.00
Summary
Over the next 5 years I will undertake a program of research centred on reducing the impact of blood-borne viruses (BBVs) and sexually transmitted infections (STIs) in vulnerable populations, particularly young people. I will study how these infections are transmitted, associated risk behaviours including drug and alcohol use and sexual risk, and develop interventions to improve the detection and management of infected individuals.
Increasing Knowledge About Substance Use, Mental Health And Harms, And Interventions To Prevent And Reduce Harm
Funder
National Health and Medical Research Council
Funding Amount
$849,540.00
Summary
This Fellowship comprises three programmes of work: 1. epidemiology of illicit drug use (including the natural history of use: incidence, prevalence, persistence, desistance and relapse), contribution to the burden of disease; 2. Pharmaceutical opioids, the impact of opioid dependence, and treatments to reduce harm; 3. Risk and resilience in young people. This work will inform prevention, early intervention and treatment initiatives.
Transformed Drug Policies: Integrating Empirical Evidence With Participatory Democracy
Funder
National Health and Medical Research Council
Funding Amount
$782,370.00
Summary
In my 5 year research fellowship I will lead internationally relevant research on better policy options for illegal drugs, such as methamphetamine, heroin and cannabis. Drug policy can be driven by politics and the media, rather than research evidence. I will generate a cutting edge and fresh perspective with an agile approach to new research that takes into account the rapidly changing field of drug policy. This will provide policy makers with a new framework for evidence-based policy reforms.
Monitoring And Improving The Health Of Justice-involved Populations: A Public Health Priority
Funder
National Health and Medical Research Council
Funding Amount
$713,517.00
Summary
The prison system serves as a filter for the most disadvantaged and unwell members of our community. Prisons provide a rare opportunity to initiate health care for these individuals, but health gains achieved in custody are usually lost after return to the community. The aims of this Fellowship are to (a) understand the health care needs of justice-involved people, (b) develop effective, affordable interventions to meet these needs; and (c) translate the findings of this research into policy.
Assessing The Population Health Impact Of Illicit Drug Use: Prevalence, Trajectories, And Contributions To Disease Burden
Funder
National Health and Medical Research Council
Funding Amount
$714,745.00
Summary
This Fellowship comprises three programmes of work: 1. epidemiology of illicit drug use (including the natural history of use: incidence, prevalence, persistence, desistance and relapse), contribution to the burden of disease; 2. risk and resilience in young people: drug use, drug trajectories, and adult outcomes of drug use; 3.The use and misuse of pharmaceutical opioids: drivers, trajectories, and outcomes. This work will inform prevention, early intervention and treatment initiatives.
Understanding Australia’s Drug Use: Prescription Psychotropics, Recreational Drugs And Novel Emerging Psychoactive Substances
Funder
National Health and Medical Research Council
Funding Amount
$763,409.00
Summary
Australians are consuming record levels of drugs that affect their mood and behaviour, both prescribed and illicit. They are also consuming an increasing array of novel synthetic drugs, the effects of which are largely unknown. Professor Iain McGregor engages in innovative research that examines the drugs we take, their effects on the brain, and their risks and benefits. His team also develops new medications that may become future treatments for anxiety, depression and addictions.